单纯化学血管成形术与化学联合机械血管成形术治疗动脉瘤性出血后脑血管痉挛:一项先导性随机对照研究
这项前瞻性单中心干预性先导随机试验将12例动脉瘤性蛛网膜下腔出血后难治性脑血管痉挛患者随机分配至单纯动脉内尼莫地平组或尼莫地平联合机械血管成形术组,共进行44次颈内动脉操作。联合机械血管成形术组在血管直径增加、灌注改善和减少再治疗方面均优于单纯药物组,且安全性可接受;作者认为需要更大规模的多中心试验。
要点
- 尼莫地平联合机械血管成形术组TTD中位变化-42%,优于单纯尼莫地平组的-14%(P=.006)。
- 联合组动脉直径中位增加+91%,单纯药物组为+30%(P<.001)。
- 联合组再治疗率33%(7/21),低于单纯药物组的96%(22/23)(P<.001)。
核心结论
- 在难治性血管痉挛中,动脉内尼莫地平联合机械血管成形术较单纯尼莫地平与更大的血管扩张、更好的灌注和更少的再治疗相关,安全性可接受;作者认为需要更大规模的多中心试验。
研究设计与样本
- 前瞻性、单中心、干预性先导随机对照试验,共12例患者、44次颈内动脉操作,随机分为单纯动脉内化学血管成形术组(对照组,尼莫地平23次操作)和化学联合机械血管成形术组(治疗组,尼莫地平加血管成形术21次操作);主要终点为CT灌注上专用动脉供血区引流时间(TTD)治疗前后的变化。
诊断标准与关键数值
- 主要终点为CT灌注TTD中位百分比变化:尼莫地平组-14%(IQR -37至9),尼莫地平联合血管成形术组-42%(IQR -54至-30)(P=.006);动脉直径百分比变化分别为+30%(IQR 17-40)和+91%(IQR 68-130)(P<.001)。
临床应用与阅片要点
- 作者认为,在蛛网膜下腔出血后难治性血管痉挛中,动脉内尼莫地平联合机械血管成形术较单纯尼莫地平与更大的血管扩张、更好的灌注和更少的再治疗相关,安全性可接受;并指出需要更大规模的多中心试验。
局限性
- 作者指出需要更大规模的多中心试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Refractory cerebral vasospasm (CV) and delayed cerebral ischemia after aneurysmal SAH are associated with high morbidity and mortality; CV may recur despite intra-arterial chemical treatment and the role of mechanical angioplasty remains unclear. We aim to define the role of mechanical angioplasty in addition to chemical angioplasty.
MATERIALS AND METHODS: In a prospective, monocentric, interventional trial, we randomly assigned patients with a refractory CV within the ICAs and an indication for endovascular management to undergo intra-arterial chemical angioplasty (control group) or chemical plus mechanical angioplasty (treatment group). The primary end point was the change of brain perfusion in the dedicated arterial territory measured by the time to drain (TTD) on CT perfusion, before and after treatment.
RESULTS: A total of 12 patients underwent 44 ICA procedures: 23 were assigned to nimodipine and 21 to nimodipine plus angioplasty. The median percent change in TTD was -14% (interquartile range [IQR], -37 to 9) with nimodipine and -42% (IQR, -54 to -30) with nimodipine plus angioplasty (P = .006). The percent change in arterial diameter was +30% (IQR, 17-40) and +91% (IQR, 68-130), respectively (P < .001). Re-treatment was required in 22 of 23 procedures (96%) in the nimodipine group and in 7 of 21 procedures (33%) in the angioplasty group (P < .001). Complications occurred in 2 of 44 procedures (4.5%), both in the angioplasty group, with no disabling sequelae.
CONCLUSIONS: In this pilot randomized study, the addition of mechanical angioplasty to intra-arterial nimodipine for refractory vasospasm after subarachnoid hemorrhage was associated with greater vessel dilation, improved perfusion, and fewer re-treatments than nimodipine alone, with an acceptable safety profile. Larger, multicenter trials are warranted. (ClinicalTrials.gov number, NCT05268445).
引用
- Guenego A, Salim HA, Taccone FS, et al. Chemical Angioplasty Alone versus Chemical and Mechanical Angioplasty for Cerebral Vasospasm after Aneurysmal Hemorrhage: A Pilot Randomized Controlled Study. AJNR Am J Neuroradiol. 2026. PMID: 41962956. doi:10.3174/ajnr.A9194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。